These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3090925)

  • 1. [Hemodynamic repercussions and clinical tolerance of 6 class I anti-arrhythmia agents in acute myocardial infarction].
    Bernard R; Renard M; Shita A; de Hemptinne J; Gillet JM; Lewinson H; Liebens I; Waterschoot P
    Ann Cardiol Angeiol (Paris); 1986 Apr; 35(4):195-8. PubMed ID: 3090925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New antiarrythmic drugs: mexiletine, tocainide, lorcainide, encainide, flecainide, propafenone, cipralan, sotalol].
    Touboul P; Kirkorian G; Atallah G; Moleur P
    Ann Cardiol Angeiol (Paris); 1982 Dec; 31(7):531-7. PubMed ID: 6820620
    [No Abstract]   [Full Text] [Related]  

  • 3. New drugs in the management of ventricular arrhythmias.
    Sanna GP
    G Ital Cardiol; 1984 Oct; 14(10):788-97. PubMed ID: 6083894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemodynamic reactions after intravenous injection of lorcainide hydrochloride in acute myocardial infarction.
    Shita A; Bernard R; Mostinckx R; Debacker M
    Eur J Cardiol; 1981; 12(5):237-42. PubMed ID: 7250167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical profiles of newer class I antiarrhythmic agents--tocainide, mexiletine, encainide, flecainide and lorcainide.
    Pottage A
    Am J Cardiol; 1983 Sep; 52(6):24C-31C. PubMed ID: 6414279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class IB antiarrhythmic drugs: tocainide, mexiletine, and moricizine.
    Snyder DW
    J La State Med Soc; 1989 May; 141(5):21-5. PubMed ID: 2499645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction.
    Lotto A; Finzi A; Massari FM; Pagnoni F; Valentini R; Ambrosini F; Lo Masto M
    G Ital Cardiol; 1984 Oct; 14(10):762-7. PubMed ID: 6519385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lorcainide in the prophylaxis of ventricular arrhythmias in acute myocardial infarction.
    Leinonen H; Heikkilä J; Sundberg S; Gordin A
    Ann Clin Res; 1984; 16(1):18-22. PubMed ID: 6378045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mexiletine and tocainide: orally active congeners of lidocaine.
    Wulf BG
    Clin Pharm; 1983; 2(4):340-6. PubMed ID: 6411416
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the efficacy of newly developed antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias.
    Hellestrand KJ
    Eur Heart J; 1984 Sep; 5 Suppl B():87-94. PubMed ID: 6437822
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug therapy of arrhythmia in coronary cardiopathy].
    Lüderitz B
    Clin Ter; 1983 Apr; 105(1):3-11. PubMed ID: 6189663
    [No Abstract]   [Full Text] [Related]  

  • 12. Tocainide and mexiletine. Orally effective lidocaine analogues.
    Roden DM
    Arch Intern Med; 1985 Mar; 145(3):417-8. PubMed ID: 3919665
    [No Abstract]   [Full Text] [Related]  

  • 13. [New anti-arrhythmia drugs].
    Vidal Garate J; Romero-Ayala LC; Cárdenas Loaeza M
    Arch Inst Cardiol Mex; 1983; 53(2):159-78. PubMed ID: 6411015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy with investigational antiarrhythmic drugs.
    Mead RH; Harrison DC
    Med Clin North Am; 1984 Sep; 68(5):1321-37. PubMed ID: 6436596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tocainide--an alternative to mexiletine.
    Drug Ther Bull; 1982 Jul; 20(14):55-6. PubMed ID: 6814882
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemodynamic effects of concurrent administration of metoprolol and tocainide in acute myocardial infarction.
    Renard MB; Bernard RM; Ewalenko MB; Englert M
    J Cardiovasc Pharmacol; 1983; 5(1):116-20. PubMed ID: 6186845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mexiletine and tocainide: a profile of two lidocaine analogs.
    Woosley RL
    Ration Drug Ther; 1987 Mar; 21(3):1-7. PubMed ID: 3116601
    [No Abstract]   [Full Text] [Related]  

  • 18. [Xylocaine--anti-arrhythmic activity, clinical tolerance and hemodynamic repercussions (comparison with ajamline)].
    Bernard R; Vainsel H; Lewinson H; Renta C; Cornil A
    G Ital Cardiol; 1972; 2(1):159-60. PubMed ID: 5011999
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of class I anti-arrhythmia agents on the signal-averaged ECG].
    Goedel-Meinen L; Hofmann M; Schmidt G; Barthel P; Baedeker W; Blömer H
    Herz; 1988 Jun; 13(3):188-96. PubMed ID: 3136064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of old and new antiarrhythmic drugs.
    Siddoway LA; Roden DM; Woosley RL
    Cardiovasc Clin; 1985; 15(3):199-248. PubMed ID: 2870805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.